Human recombinant granulocyte-macrophage colony-stimulating factor in pediatric oncology practice.
Pediatr Hematol Oncol
; 11(2): 201-5, 1994.
Article
de En
| MEDLINE
| ID: mdl-8204446
ABSTRACT
This paper reports preliminary experiences with human recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) in children with malignant diseases administered for three indications (1) chemotherapy-induced neutropenia and sepsis, (2) prolonged neutropenia decreasing dose intensity, and (3) prevention of neutropenia after sublethal doses of chemotherapy. It was concluded that in the daily dose of 5 micrograms/kg subcutaneously, GM-CSF is capable of reducing the duration of chemotherapy-induced neutropenia and may be an effective tool in maintaining dose intensity and achieving dose escalation.
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Facteur de stimulation des colonies de granulocytes et de macrophages
/
Tumeurs
/
Neutropénie
Limites:
Adolescent
/
Child
/
Child, preschool
/
Humans
/
Infant
Langue:
En
Journal:
Pediatr Hematol Oncol
Sujet du journal:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Année:
1994
Type de document:
Article
Pays d'affiliation:
Hongrie